List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days. Pharming Group N.V.

The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect ...

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...